Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 2/20 | 0.34 |
| ▸ | IL17A | Q16552 | 3/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953347 | 1.00 | IGF1R (0.34) | IGF1RIL17AAAK1CYP3A4MAPK14 | |
| SCHEMBL30953369 | 0.86 | IGF1R (0.35) | IGF1RIL17AAAK1CYP3A4MAPK14 | |
| Hydrochloric Acid SCHEMBL30953252 | 0.84 | NR3C2 (0.37) | IL17ANR3C2CDK5DYRK1ACDK5R1 | |
| SCHEMBL30953350 | 0.83 | CTSL (0.37) | — | |
| SCHEMBL30953422 | 0.83 | CTSL (0.37) | — | |
| SCHEMBL30953265 | 0.83 | CTSL (0.37) | — | |
| SCHEMBL30953017 | 0.83 | IL17A (0.36) | IGF1RIL17AMAPK14GSK3B | |
| Hydrochloric Acid SCHEMBL30953395 | 0.82 | SLC5A1 (0.33) | IGF1RIL17ANR3C2 | |
| SCHEMBL30953226 | 0.81 | NR3C2 (0.37) | IGF1RIL17AMAPK14NR3C2CDK5 | |
| Hydrochloric Acid SCHEMBL30953230 | 0.81 | NR3C2 (0.36) | IGF1RIL17AMAPK14NR3C2CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |